Form 4: Amylyx Pharmaceuticals Chief Legal Officer Sells Shares to Cover Tax Obligations

Gina Mazzariello, Chief Legal Officer of Amylyx Pharmaceuticals, sold shares of common stock on September 30, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On September 30, 2024, Gina Mazzariello, the Chief Legal Officer of Amylyx Pharmaceuticals, sold 8,709 shares of common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price of $3.1967, with individual transactions ranging from $3.12 to $3.235.
• Following the transaction, Mazzariello directly owns 142,768 shares of Amylyx Pharmaceuticals.
• The sale was automatic and not at the discretion of the reporting person.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction (sale of shares for tax obligations) by a company executive, which is neither particularly positive nor negative. It's a neutral event in the context of the company's overall performance.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company's future.

Stakeholder Impact

• The sale of shares by a company executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant effect given the reason for the sale.

Key Dates